Form 8-K · Current Report · Filed 2024-11-06
Cencora Announces Fiscal 2024 Results and Declares Quarterly Dividend
On November 6, 2024, Cencora, Inc. reported its financial results for the fiscal year and fourth quarter ended September 30, 2024. The company announced a revenue increase of 12.1% for the fiscal year to $294.0 billion and a 14.7% increase for the fourth quarter to $79.1 billion. Despite the revenue growth, the company's GAAP diluted earnings per share (EPS) for the fiscal year and fourth quarter declined due to increased operating expenses and a goodwill impairment charge related to PharmaLex. Cencora also announced an 8% increase in its quarterly dividend, now set at $0.55 per common share. The company provided fiscal 2025 guidance, which included adjusted operating income growth expectations of 5 to 6.5 percent and adjusted diluted EPS growth of 8 to 10 percent.
- Filer
- Cencora Inc. COR · NYSE
- Filed
- Accession
- 0001140859-24-000148
- CIK
- 0001140859
- Signal
- Low impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Results of Operations and Financial Condition
Regulation FD Disclosure
Financial Statements and Exhibits
Market reaction
Close before filing
$233.99
Next session
+5.9%
Since filing
+33.1%
Latest close
$311.34
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from COR reporting the same item, with the next session's move:
Exhibits (1)
About Cencora Inc.
Cencora Inc., formerly known as AmerisourceBergen Corporation, represents a pivotal entity in the global healthcare distribution and services sector. As a leading pharmaceutical sourcing and distribution services company, Cencora Inc. plays a critical role in ensuring the efficient supply of pharmaceutical products to a range of healthcare providers, including hospitals, pharmacies, and clinics. Its business model is centered on the seamless integration of logistics, consulting services, and the provision of innovative solutions aimed at improving pharmaceutical supply chain operations. Cencora Inc. impacts various segments of the healthcare industry by enhancing the availability and accessibility of healthcare products. Known for its global reach and extensive network of distribution centers, the company supports the delivery of critical medications and healthcare products across numerous geographies. Cencora Inc.'s significance in the market is underscored by its ability to partner with pharmaceutical manufacturers and healthcare providers to streamline processes, reduce costs, and improve patient outcomes. Headquartered in Conshohocken, Pennsylvania, Cencora Inc. remains a cornerstone of the healthcare distribution market, focusing on sustainability, innovation, and strategic collaborations.
Never miss another COR filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.